<VariationArchive RecordType="classified" VariationID="1285514" VariationName="NM_001282225.2(ADA2):c.158del (p.Asn53fs)" VariationType="Deletion" Accession="VCV001285514" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-03-05" MostRecentSubmission="2022-03-05">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1275357" VariationID="1285514">
      <GeneList>
        <Gene Symbol="ADA2" FullName="adenosine deaminase 2" GeneID="51816" HGNC_ID="HGNC:1839" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q11.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="17178790" stop="17221848" display_start="17178790" display_stop="17221848" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="17660191" stop="17690778" display_start="17660191" display_stop="17690778" Strand="-" />
          </Location>
          <OMIM>607575</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001282225.2(ADA2):c.158del (p.Asn53fs)</Name>
      <CanonicalSPDI>NC_000022.11:17209519:TT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>22q11.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="17209520" stop="17209520" display_start="17209520" display_stop="17209520" variantLength="1" positionVCF="17209519" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="17690410" stop="17690410" display_start="17690410" display_stop="17690410" variantLength="1" positionVCF="17690409" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>N11fs</ProteinChange>
      <ProteinChange>N53fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.17690411del" Assembly="GRCh37">
            <Expression>NC_000022.10:g.17690411del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.17209521del" Assembly="GRCh38">
            <Expression>NC_000022.11:g.17209521del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033943.1" sequenceAccession="NG_033943" sequenceVersion="1" change="g.17335del">
            <Expression>NG_033943.1:g.17335del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282225.2" sequenceAccession="NM_001282225" sequenceVersion="2" change="c.158del" MANESelect="true">
            <Expression>NM_001282225.2:c.158del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269154.1" sequenceAccession="NP_001269154" sequenceVersion="1" change="p.Asn53fs">
            <Expression>NP_001269154.1:p.Asn53fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282226.2" sequenceAccession="NM_001282226" sequenceVersion="2" change="c.158del">
            <Expression>NM_001282226.2:c.158del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269155.1" sequenceAccession="NP_001269155" sequenceVersion="1" change="p.Asn53fs">
            <Expression>NP_001269155.1:p.Asn53fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282227.2" sequenceAccession="NM_001282227" sequenceVersion="2" change="c.32del">
            <Expression>NM_001282227.2:c.32del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269156.1" sequenceAccession="NP_001269156" sequenceVersion="1" change="p.Asn11fs">
            <Expression>NP_001269156.1:p.Asn11fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282228.2" sequenceAccession="NM_001282228" sequenceVersion="2" change="c.32del">
            <Expression>NM_001282228.2:c.32del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269157.1" sequenceAccession="NP_001269157" sequenceVersion="1" change="p.Asn11fs">
            <Expression>NP_001269157.1:p.Asn11fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282229.2" sequenceAccession="NM_001282229" sequenceVersion="2" change="c.-38-2230del">
            <Expression>NM_001282229.2:c.-38-2230del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1217" sequenceAccession="LRG_1217">
            <Expression>LRG_1217:g.17335del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1217t1" sequenceAccession="LRG_1217t1">
            <Expression>LRG_1217t1:c.158del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1217p1" sequenceAccession="LRG_1217p1" change="p.Asn53fs">
            <Expression>LRG_1217p1:p.Asn53fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2062393838" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001282225.2(ADA2):c.158del (p.Asn53fs) AND Vasculitis due to ADA2 deficiency" Accession="RCV001706871" Version="2">
        <ClassifiedConditionList TraitSetID="13385">
          <ClassifiedCondition DB="MedGen" ID="C3887654">Vasculitis due to ADA2 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-01-31" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-05" MostRecentSubmission="2022-03-05">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <DescriptionHistory Dated="2022-03-04">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="13385" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6159" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Polyarteritis nodosa, childhoood-onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME</ElementValue>
                <XRef Type="MIM" ID="615688" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0004" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Vasculitis due to ADA2 deficiency</ElementValue>
                <XRef ID="MONDO:0014306" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VAIHS</ElementValue>
                <XRef Type="MIM" ID="615688" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Adenosine deaminase 2 deficiency (DADA2) is a complex systemic autoinflammatory disorder in which vasculopathy/vasculitis, dysregulated immune function, and/or hematologic abnormalities may predominate. Inflammatory features include intermittent fevers, rash (often livedo racemosa/reticularis), and musculoskeletal involvement (myalgia/arthralgia, arthritis, myositis). Vasculitis, which usually begins before age ten years, may manifest as early-onset ischemic (lacunar) and/or hemorrhagic strokes, or as cutaneous or systemic polyarteritis nodosa. Hypertension and hepatosplenomegaly are often found. More severe involvement may lead to progressive central neurologic deficits (dysarthria, ataxia, cranial nerve palsies, cognitive impairment) or to ischemic injury to the kidney, intestine, and/or digits. Dysregulation of immune function can lead to immunodeficiency or autoimmunity of varying severity; lymphadenopathy may be present and some affected individuals have had lymphoproliferative disease. Hematologic disorders may begin early in life or in late adulthood, and can include lymphopenia, neutropenia, pure red cell aplasia, thrombocytopenia, or pancytopenia. Of note, both interfamilial and intrafamilial phenotypic variability (e.g., in age of onset, frequency and severity of manifestations) can be observed; also, individuals with biallelic ADA2 pathogenic variants may remain asymptomatic until adulthood or may never develop clinical manifestations of DADA2.</Attribute>
                <XRef ID="NBK544951" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12383" />
                <XRef ID="12383" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31393689</ID>
                <ID Source="BookShelf">NBK544951</ID>
              </Citation>
              <XRef ID="404553" DB="Orphanet" />
              <XRef ID="C3887654" DB="MedGen" />
              <XRef ID="MONDO:0014306" DB="MONDO" />
              <XRef Type="MIM" ID="615688" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3800062" SubmissionDate="2022-03-02" DateLastUpdated="2022-03-05" DateCreated="2021-09-26">
        <ClinVarSubmissionID localKey="CVb_1371|OMIM:615688" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001934420" DateUpdated="2022-03-05" DateCreated="2021-09-26" Type="SCV" Version="2" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Criteria: PVS1, PM2_SUP, PP4_VSTR This variant was identified as compound heterozygous with NM_001282225.2:c.2T&gt;A.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001282225.2:c.158del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615688" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10413949</SubmissionName>
          <SubmissionName>SUB11147409</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3800062" TraitType="Disease" MappingType="XRef" MappingValue="615688" MappingRef="OMIM">
        <MedGen CUI="C3887654" Name="Vasculitis due to ADA2 deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

